A Novel Approach for Sericin-Conjugated Silver Nanoparticle Synthesis and Their Potential as Microbicide Candidates
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Silver nanoparticles have been widely applied for biomedical areas owing to their potent antiviral and antibacterial activities. Synthesis of silver nanoparticles using biomacromolecules is more efficient, environment-friendly, and cost-saving compared with the traditional approach. In this paper, a novel approach was developed to establish a reaction system with Ag+-BH4--sericin to synthesize silver nanoparticles conjugated to sericin (AgNPs-Sericin). Sericin could be as a good dispersant and stabilizing agent, which is able to modify nanoscaled AgNPs, the average diameter of which was only 3.78 ± 1.14nm prepared in a 0.3 mg/ml sericin solution. The characterizations of the AgNPs-Sericin were determined by FTIR, thermogravimetry, and XRD analyses. The results showed that the synthesized AgNPs conjugated with sericin as organic phase. Via SAED and XRD analysis, we showed that these AgNPs formed polycrystalline powder with a face-centered cubic structure of bulk metals. Moreover, we investigated the antiviral and antibacterial activities of AgNPs-Sericin, and the results showed that AgNPs-Sericin exhibited potent anti-HIV-1 activity against CCR5-tropic and CXCR4-tropic strains, but no significant cytotoxicity was found toward human genital epithelial cells compared with free silver ions, which are accepted as a commonly used potent antimicrobial agent. Moreover, its antibacterial activity was determined via flow cytometry. The results showed that AgNPs-Sericin could suppress gram-negative (E. coli) and grampositive (S. aureus) bacteria, but more was potent for the gram-negative one. We concluded that our AgNPs-Sericin could be a potential candidate as a microbicide or antimicrobial agent to prevent sexually transmitted infections.
Abstract
Silver nanoparticles have been widely applied for biomedical areas owing to their potent antiviral and antibacterial activities. Synthesis of silver nanoparticles using biomacromolecules is more efficient, environment-friendly, and cost-saving compared with the traditional approach. In this paper, a novel approach was developed to establish a reaction system with Ag+-BH4--sericin to synthesize silver nanoparticles conjugated to sericin (AgNPs-Sericin). Sericin could be as a good dispersant and stabilizing agent, which is able to modify nanoscaled AgNPs, the average diameter of which was only 3.78 ± 1.14nm prepared in a 0.3 mg/ml sericin solution. The characterizations of the AgNPs-Sericin were determined by FTIR, thermogravimetry, and XRD analyses. The results showed that the synthesized AgNPs conjugated with sericin as organic phase. Via SAED and XRD analysis, we showed that these AgNPs formed polycrystalline powder with a face-centered cubic structure of bulk metals. Moreover, we investigated the antiviral and antibacterial activities of AgNPs-Sericin, and the results showed that AgNPs-Sericin exhibited potent anti-HIV-1 activity against CCR5-tropic and CXCR4-tropic strains, but no significant cytotoxicity was found toward human genital epithelial cells compared with free silver ions, which are accepted as a commonly used potent antimicrobial agent. Moreover, its antibacterial activity was determined via flow cytometry. The results showed that AgNPs-Sericin could suppress gram-negative (E. coli) and grampositive (S. aureus) bacteria, but more was potent for the gram-negative one. We concluded that our AgNPs-Sericin could be a potential candidate as a microbicide or antimicrobial agent to prevent sexually transmitted infections.
참고문헌 (25)
- Alanis AJ, "Resistance to antibiotics: are we in the postantibiotic era?", Arch. Med. Res., 36, pp.697~705 (2005)[DOI]
- Fauci AS, "The AIDS epidemic - considerations for the 21st century", N. Engl. J. Med., 341, pp.1046~1050 (1999)[DOI]
- Kahn JO, "Acute human immunodeficiency virus type 1 infection", N. Engl. J. Med., 339, pp.33~39 (1998)[DOI]
- Stone A, "Microbicides: a new approach to preventing HIV and other sexually transmitted infections", Nat. Rev. Drug Discov., 1, pp.977~985 (2002)[DOI]
- Balzarini J, "Microbicide drug candidates to prevent HIV infection", Lancet, 369, pp.787~797 (2007)[DOI]
- Neu HC, "The crisis in antibiotic resistance", Science, 257, pp.1064~1073 (1992)[DOI]
- Bonnemann H, "Nanoscopic metal particles − synthetic methods and potential applications", Eur. J. Inorg. Chem., 2001, pp.2455~2480 (2001)[DOI]
- Hirsch LR, "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance", Proc. Natl. Acad. Sci. USA, 100, pp.13549~13554 (2003)[DOI]
- Liau S, "Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions", Lett. Appl. Microbiol., 25, pp.279~283 (1997)[DOI]
- Nomiya K, "Synthesis and structural characterization of silver(I), aluminium(III) and cobalt(II) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver(I)-oxygen bonding complexes on the antimicrobial activities", J. Inorg. Biochem., 98, pp.46~60 (2004)[DOI]
- Gupta A, "Molecular genetics: silver as a biocide: will resistance become a problem?", Nat. Biotechnol., 16, pp.888~ (1998)[DOI]
- Fedlheim DL, "Metal Nanoparticles: Synthesis, Characterization, and Applications" (2001), CRC Press
- Lok C-N, "Proteomic analysis of the mode of antibacterial action of silver nanoparticles", J. Proteome Res., 5, pp.916~924 (2006)[DOI]
- Das R, "Preparation and antibacterial activity of silver nanoparticles", J. Biomater. Nanobiotechnol., 2, pp.472~475 (2011)[DOI]
- Li C, "The antifungal activity of graphene oxide–silver nanocomposites", Biomaterials, 34, pp.3882~3890 (2013)[DOI]
- Elechiguerra JL, "Interaction of silver nanoparticles with HIV-1", J. Nanobiotechnol., 3, pp.1~10 (2005)[DOI]
- Baram-Pinto D, "Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate", Bioconjug. Chem., 20, pp.1497~1502 (2009)[DOI]
- AshaRani P, "Cytotoxicity and genotoxicity of silver nanoparticles in human cells", ACS Nano, 3, pp.279~290 (2008)
- Zhang YQ, "Applications of natural silk protein sericin in biomaterials", Biotechnol. Adv., 20, pp.91~100 (2002)[DOI]
- Li M, "Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies", J. Virol., 79, pp.10108~10125 (2005)[DOI]
- Johnson V, "Infectivity assay (virus yield assay);Techniques in HIV research", pp.71~76 (1990), Stockton Press
- Pan H, "A comparison of conventional methods for the quantification of bacterial cells after exposure to metal oxide nanoparticles", BMC Microbiol., 14, pp.222~ (2014)[DOI]
- Morones JR, "The bactericidal effect of silver nanoparticles", Nanotechnology, 16, pp.2346~2353 (2005)[DOI]
- Ravichandran R, "Nanotechnology-based drug delivery systems", Nanobiotechnology, 5, pp.17~33 (2009)[DOI]
- Galdiero S, "Silver nanoparticles as potential antiviral agents", Molecules, 16, pp.8894~8918 (2011)[DOI]